From: Analysis of prognostic factors of patients with malignant peritoneal mesothelioma
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Age (years) | 1.012 | 0.983–1.041 | 0.431 | 0.993 | 0.963–1.025 | 0.672 |
Gender (male/female) | 0.747 | 0.448–1.245 | 0.263 | 0.959 | 0.549–1.674 | 0.882 |
BMI | 0.949 | 0.891–1.011 | 0.105 | |||
Asbestos exposure (yes/no) | 1.082 | 0.588–1.992 | 0.8 | 1.135 | 0.636–2.025 | 0.669 |
Histological subtype (Epithelial/biphasic + sarcomatoid) | 0.800 | 0.468–1.367 | 0.415 | |||
Treatment Cisplatin Cisplatin + pemetrexed Untreated | 0.418 | 0.263–0.664 | 0.00 | 0.475 | 0.289–0.782 | 0.003 |
WBC count | 0.966 | 0.829–1.126 | 0.661 | |||
PLT count | 1.001 | 0.998–1.004 | 0.461 | |||
NLR | 1.176 | 1.062–1.303 | 0.002 | 1.138 | 1.015–1.276 | 0.027 |
ALB | 0.920 | 0.872–0.971 | 0.002 | 0.935 | 0.879–0.994 | 0.031 |